221 related articles for article (PubMed ID: 25359222)
1. Novel antibody associations in immune-mediated necrotising myopathy without inflammation.
Curtin D; Costigan D; McCarthy C; Jansen M; Farrell M; Reid V; O'Rourke K
Ir J Med Sci; 2016 Nov; 185(4):941-943. PubMed ID: 25359222
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
3. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase].
Hinschberger O; Lohmann C; Lannes B; Martzolff L; Vo BD; Jaeger-Bizet F; Ciobanu E; Kieffer P
Rev Med Interne; 2014 Aug; 35(8):546-9. PubMed ID: 23910221
[TBL] [Abstract][Full Text] [Related]
4. Necrotizing myopathies: beyond statins.
Mammen AL
Curr Opin Rheumatol; 2014 Nov; 26(6):679-83. PubMed ID: 25203117
[TBL] [Abstract][Full Text] [Related]
5. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
Mammen AL
Nat Rev Neurol; 2011 Jun; 7(6):343-54. PubMed ID: 21654717
[TBL] [Abstract][Full Text] [Related]
7. Statin-Associated Autoimmune Myopathy: A Systematic Review of 100 Cases.
Nazir S; Lohani S; Tachamo N; Poudel D; Donato A
J Clin Rheumatol; 2017 Apr; 23(3):149-154. PubMed ID: 28277343
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer.
Mizuma A; Kouchi M; Netsu S; Yutani S; Kitao R; Suzuki S; Murata K; Nagata E; Takizawa S
Intern Med; 2017; 56(14):1915-1918. PubMed ID: 28717093
[TBL] [Abstract][Full Text] [Related]
9. Immune-mediated statin myopathy.
Loganathan P; Oddis CV; Aggarwal R
Expert Rev Clin Immunol; 2016; 12(1):33-8. PubMed ID: 26515829
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune necrotising myopathy and HMGCR antibodies.
Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S
Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
[TBL] [Abstract][Full Text] [Related]
11. [Autoimmune myopathy associated with statin use].
Ljøstad U; Mygland Å
Tidsskr Nor Laegeforen; 2016 Sep; 136(16):1360-2. PubMed ID: 27637055
[TBL] [Abstract][Full Text] [Related]
12. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide.
Fernandes das Neves M; Caetano J; Oliveira S; Delgado Alves J
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26240092
[TBL] [Abstract][Full Text] [Related]
14. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
Mohassel P; Mammen AL
Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
16. An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy.
Nichols L; Pfeifer K; Mammen AL; Shahnoor N; Konersman CG
J Gen Intern Med; 2015 Dec; 30(12):1879-83. PubMed ID: 25855481
[TBL] [Abstract][Full Text] [Related]
17. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
18. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.
Drouot L; Allenbach Y; Jouen F; Charuel JL; Martinet J; Meyer A; Hinschberger O; Bader-Meunier B; Kone-Paut I; Campana-Salort E; Eymard B; Tournadre A; Musset L; Sibilia J; Marie I; Benveniste O; Boyer O;
Arthritis Res Ther; 2014 Feb; 16(1):R39. PubMed ID: 24484965
[TBL] [Abstract][Full Text] [Related]
19. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
[TBL] [Abstract][Full Text] [Related]
20. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA
Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
